Of the different CSC markers identified to date in gynecologic malignancies [10,11,12,13,14,15,16,17,18,19,20,22,23], ALDH is widely recognized as a highly robust CSC marker across the vast majority of cancer types, including gynecologic CSCs. The gene discussed is LDHA; the disease is cancer.